Accès ouvert
2026
article
OpenAlex
Sean A. Gray, Jennifer Knight Davis, Conrad M Puff-Carter, Vishal Khatri et autres
Abstract This study was conducted to yield a robust and scalable manufacturing process for a candidate vaccine for human lymphatic filariasis (LF) - a tropical parasitic infection transmitted by mosquitoes. In previous studies, we demonstrated that removing an affinity purification tag from …
us, in
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Nithila Saravanan, Sean A. Gray, Jennifer Davis, Conrad M. Puff-Carter et autres
Abstract This study was conducted to develop a robust, scalable manufacturing process for the candidate vaccine rBmHAXT for human lymphatic filariasis (LF). During scale-up production, rBmHAXT showed significant antigen aggregation leading to a loss of purified vaccine antigens. This project aims to …
2024
article
OpenAlex
Steven J. Ackerman, Amir F. Kagalwalla, Zhaoxing Pan, Joshua B. Wechsler et autres
INTRODUCTION: Endoscopy, standard-of-care for monitoring eosinophilic esophagitis (EoE), assesses mucosal inflammation. The Esophageal String Test (EST), a minimally invasive swallowed capsule and immunoassays, quantifies EoE inflammation. We determined whether the EST/EoEScore can monitor disease in patients undergoing treatment. METHODS: Thirty-three samples from …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Ishwar S Singh, S. L. Hoti, Nikhil Chauhan, Rajesh Kumar Joshi et autres
in
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Valeria Melendez, Cheri Turner, Vishal Khatri, Jenn Davis et autres
This study was conducted to optimize a fusion protein vaccine for translational development as a vaccine against the human tropical parasitic infection, lymphatic filariasis (LF). The vaccine candidate, His-tagged r Bm HAXT was developed previously in our laboratory and was tested in …
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Vishal Khatri, Nikhil Chauhan, Ramaswamy Kalyanasundaram
The use of parasites or their products for treating chronic inflammation associated diseases (CIADs) has generated significant attention recently. Findings from basic and clinical research have provided valuable information on strengthening the notion that parasites' molecules can be developed as biotherapeutic agents. …
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Vishal Khatri, Nikhil Chauhan, Ramaswamy Kalyanasundaram
us
(code pays fourni par la source)
2020
conference-abstract
OpenAlex
Vishal Khatri, Nikhil Chauhan, S B Prasanna Kumar, Ramaswamy Kalyanasundaram
Abstract The therapeutic potential of filarial parasite derived recombinant cystatin was reported previously by our group in the mouse model of colitis. We showed that cystatin-treatment elevated IL-10+FoxP3+Tregs, IgM+B1a cells and AAMs in the colon and peritoneal cavity. In this study, we …
us
(code pays fourni par la source)
2020
conference-abstract
OpenAlex
Nikhil Chauhan, Vishal Khatri, S B Prasanna Kumar, Valeria Malendez et autres
Abstract In this study, we cloned the homologue of macrophage migration inhibitory factor (MIF) secreted by the human filarial parasite Wuchereria bancrofti (rWbaMIF-2) and evaluated its potential in ameliorating inflammation in a dextran sulfate sodium salt (DSS)-induced colitis model. DSS administration resulted …
us
(code pays fourni par la source)
2020
article
OpenAlex
Shriram Ramani, Nikhil Chauhan, Vishal Khatri, Connie Vitali et autres
Immunomodulatory molecules produced by helminth parasites are receiving much attention recently as novel therapeutic agents for inflammation and autoimmune diseases. In this study, we show that macrophage migration inhibitory factor (MIF) homologue from the filarial parasite, Wuchereria bancrofti (rWbaMIF-2), can suppress inflammation …
us
(code pays fourni par la source)
Accès ouvert
2019
review
OpenAlex
Ramaswamy Kalyanasundaram, Vishal Khatri, Nikhil Chauhan
us
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Nalini Bisht, Vishal Khatri, Nikhil Chauhan, Ramaswamy Kalyanasundaram
Potential alternative therapeutic strategies for immune-mediated disorders are being increasingly recognized and are studied extensively. We previously reported the therapeutic potential of Brugia malayi derived recombinant cystatin (rBmaCys) in attenuating clinical symptoms of experimental colitis. The aim of this study was to …
us
(code pays fourni par la source)